Revolution Medicines · 1 month ago
Senior Director, Global Medical Affairs, Lung
United States
Full-time
Remote
Director/Executive
$224K/yr - $280K/yr
14+ years expRevolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies for RAS-addicted cancers. The Senior Director, Global Medical Affairs, will be responsible for developing and executing the Global Medical Affairs strategy with a focus on launch readiness and life cycle management, collaborating with cross-functional teams to design and implement comprehensive strategies for lung cancer.
Health CareLife ScienceMedical
Responsibilities
Leads the development and execution the GMA strategy and medical objectives including activities related to scientific engagement and communication, evidence generation, internal education, and patient advocacy
Leads the development and execution of a Health Care Professional (HCP) engagement strategy to gather insights to shape internal programs
Acts as the medical representative on cross-functional teams
Serves as a therapeutic area content expert
Participates in the Global Medical Affairs Team (GMAT) to execute medical strategies, contribute to the operations and oversight of medical activities, and work cross-functionally to support associated pre-launch activities
Contributes to the execution of routine gap assessments leading to the development/refinement of a publication strategy, an evidence generation plan, and tactical plan as part of the overall GMA plan
Provides medical leadership in scientific engagement activities with key external stakeholders through organizing and leading advisory boards, studies investigator interactions, congress activities, and peer-to-peer discussions with the goal of communicating scientific insights to internal teams to drive strategy
Communicates clinical and scientific data to KOLs and other healthcare professionals through presentations, educational programs, and scientific discussions
Represents various medical affairs functions in cross-functional strategy team meetings including Clinical and Safety sub-teams, Global Brand Team, Global Product Team, Patient Advocacy, Market Access, and other cross-functional strategic discussions
Partners with the Clinical and MSL teams to provide enrollment, scientific, and engagement support to ensure clinical trials meet study timelines
Partners with RWE strategy and Biomarker/CDx teams on related integrated evidence generation strategies and activities as part of the GMA Plan
Partners with the Patient Advocacy and Grants teams to incorporate the patient voice and define external medical education strategies for independent grants, respectively
Provides medical expertise for scientific symposia and medical congresses and collaborate across GMA functions to develop, review, and align on key scientific communication points and medical information response documents within legal and compliance guidelines
Plays a key role in the review and approval of abstracts, manuscripts, corporate communications, and other data disclosure documents as well as internal stakeholder medical education activities related to the compound data and related competitor data
Partners with stakeholders across the organization, including, but not limited to, Clinical Development and Operations, Commercial Operations, Program Management, Business Development, Regulatory, Safety, and Compliance teams
Qualification
Required
An advanced doctorate degree (PharmD, PhD, MD, DO or equivalent) in medical/scientific area is required
14+ years of relevant experience in the biotech or pharmaceutical industry focused on Medical Affairs, with global cross-functional in-house experience and on field-based teams
Must have a strong scientific background in lung cancer with a good understanding of biomarker-driven disease and ability to effectively analyze, synthesize, and communicate complex scientific information
Direct, hands-on experience executing the activities of various functions within medical affairs (training, medical communications, medical information, expanded access programs, evidence generation, publications)
Proven track record of clinical trial support including protocol development/review, site selection support, enrollment support, and data analysis
Excellent interpersonal, written, and presentation skills with the ability to effectively communicate complex scientific data with a strong point of view to diverse audiences
Thrives in fast-paced, dynamic environment and ability to multi-task independently with limited supervision
Ability to travel to Redwood City headquarters and professional congresses (30 - 40%)
Strong networking skills with deep existing relationships with lung cancer healthcare professionals including global top key opinion leaders required
Preferred
Experience in global product launches including support of integrated brand plan ideation, regulatory submissions, reimbursement, and label development
Experience in guideline submissions (e.g. NCCN) and engagements with global health authorities preferred
Benefits
Competitive cash compensation
Robust equity awards
Strong benefits
Significant learning and development opportunities
Company
Revolution Medicines
Revolution Medicines is an innovative and dynamic organization of expert biologists, chemists, pharmacologists, clinical scientists.
501-1000 employees
H1B Sponsorship
Revolution Medicines has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (13)
2024 (18)
2023 (15)
2022 (8)
2021 (1)
2020 (2)
Funding
Current Stage
Public CompanyTotal Funding
$2.25BKey Investors
Royalty PharmaBoxer CapitalNextech Invest
2025-06-24Post Ipo Debt· $250M
2024-12-02Post Ipo Equity· $750M
2023-03-02Post Ipo Equity· $323.6M
Leadership Team
Luan Wilfong
Chief Human Resources Officer
Steve Kelsey
President
Recent News
Pharmaceutical Technology
2026-01-13
Company data provided by crunchbase